BARBIERI LINDA

Garbujo, S., Baioni, C., Banfi, A., Bolis, L., Bonvini, G., Del Favero, E., et al. (2026). Biomimetic lipid nanoparticles for RNA delivery to breast cancer microenvironment cells by enhanced homotypic and heterotypic adhesion. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 709(May 2026) [10.1016/j.jcis.2026.139972]. Dettaglio

Barbieri, L., Banfi, A., Garbujo, S., Salvioni, L., Baioni, C., Tomaino, G., et al. (2026). TEAMSTER: End-to-end pipeline for generation, processing, and automated quantitative image analysis of 3D tumour spheroids for nanobiology. METHODS, 253(September 2026), 19-30 [10.1016/j.ymeth.2026.04.015]. Dettaglio

Banfi, A., Barbieri, L., Fiandra, L., Salvioni, L., Innocenti, M., Prosperi, D. (2025). Dual-Targeting Strategy to Repurpose Cetuximab with HFn Nanoconjugates for Immunotherapy of Triple-Negative Breast Cancer. Intervento presentato a: Next Gen3ration research - September 18-19, 2025, Genoa, Italy. Dettaglio

Secchi, V., Armanni, A., Barbieri, L., Bruno, A., Colombo, A., Fumagalli, S., et al. (2025). Advanced techniques and nanotechnologies for point-of-care testing. FRONTIERS IN NANOTECHNOLOGY, 6 [10.3389/fnano.2024.1465429]. Dettaglio

Barbieri, L., Salvioni, L., Banfi, A., Garbujo, S., Fiandra, L., Baioni, C., et al. (2025). Dual-Targeting Strategy to Repurpose Cetuximab with HFn Nanoconjugates for Immunotherapy of Triple-Negative Breast Cancer. ACS APPLIED MATERIALS & INTERFACES, 17(23), 33648-33663 [10.1021/acsami.5c06626]. Dettaglio